Study Evaluating the Safety and Tolerability of NSA-789

NCT00633048 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: NSA-789
DRUG: placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer